1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AXSOME THERAPEUTICS INC
Axsome Therapeutics Inc XNAS: AXSM

Axsome Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

Read More
118.42 -4.54 (-3.69%)
56.72% Gain from 52W Low
700.7K
XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Axsome Therapeutics Inc is on 18 Sep 2025 for the purpose of Deutsche Bank Virtual BioPharm Corporate Day See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
6.7 / 100
Momentum Score
Technically Neutral
56.5 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
177
1Yr Price target upside is 49%
19 analysts

13

S

13

W

2

O

1

T

SWOT Analysis

Axsome Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..